FBP1 Antibodies

Santa Cruz Biotechnology features a diverse variety of FBP1 monoclonal antibodies for investigating fructose-1,6-bisphosphatase 1 (FBP1) in various biological processes. FBP1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBP1 is a key enzyme in gluconeogenesis, playing a critical role in the regulation of glucose metabolism. FBP1 catalyzes the conversion of fructose-1,6-bisphosphate to fructose-6-phosphate, thereby influencing energy production and storage in cells. Dysregulation of FBP1 has been implicated in various metabolic disorders, making it an important target for research in diabetes and obesity. Understanding FBP1's role in cellular metabolism can provide valuable insights into potential therapeutic strategies. Research utilizing FBP1 monoclonal antibodies can advance metabolic pathway studies and reveal new therapeutic targets. Investigating FBP1's function in glucose homeostasis may lead to breakthroughs in metabolic disease treatment. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of metabolic processes and disease mechanisms.